CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells.

Area of Science:

• Immunology
• Cell Biology

Background:

• CD40-CD40L interaction is vital for B and T cell communication and B cell differentiation.
• Understanding the impact of CD40-CD40L pathway inhibition is crucial for immune modulation.

Purpose of the Study:

• To investigate the effects of the anti-CD40 antibody CFZ534 on B cell subsets and cytokine production.
• To evaluate the anti-inflammatory potential of CD40 blockade.

Main Methods:

• Utilized a non-depleting monoclonal anti-CD40 antibody (CFZ534).
• Assessed B cell viability, proliferation, and cytokine production in response to stimuli like CpG-ODN and CD40L.
• Analyzed B and CD4+ T cell co-cultures to measure cytokine expression.

Main Results:

• CFZ534 inhibited CD40L-mediated B cell proliferation and reduced IgG/IgM-secreting cells.
• CD40 blockade increased Granzyme B production and decreased IL-10 production in transitional B cells (CD24hiCD38hi).
• CFZ534 significantly decreased pro-inflammatory cytokines (IL-6, IL-12p35, IL-23p19, TNFα) in co-cultures.

Conclusions:

• CD40 blockade with CFZ534 demonstrates an anti-inflammatory effect on B cells.
• CFZ534 hampers IgG class switching without impacting B cell viability.
• The study highlights CFZ534 as a potential therapeutic agent for immune modulation.